Exagen Inc.
XGN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 5.9% | 15.3% | -5.7% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 59.5% | 56.1% | 46.9% | 57.4% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -20% | -36.4% | -95.8% | -47.8% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -27.2% | -45.1% | -104% | -55.6% |
| EPS Diluted | -0.83 | -1.34 | -2.77 | -1.68 |
| % Growth | 38.1% | 51.6% | -64.9% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |